Oraltec

Oraltec is a Florence-based pharmaceutical company established in 2023, positioning itself in the European dental market with a specialized focus on nutraceuticals. The company directs its efforts towards developing and providing formulations designed to enhance the osteo-immune response in dental patients, collaborating closely with dentists and dental hygienists.

The venture's business model is centered on scientific research to create next-generation nutritional supplements for oral health. Oraltec emphasizes the quality of its products, using certified, high-grade raw materials and maintaining stringent controls throughout its supply chain. Its formulations are the result of dedicated research into oral pathologies and the effects of natural micronutrients on health, adhering to scientific criteria. This approach provides dental professionals with complementary tools to support patient care before, during, and after dental procedures. The products are sold directly to consumers and professionals, with an e-commerce platform that facilitates purchases.

Founded in 2023, the company quickly gained traction by securing a place in an accelerator program with IKIGAI Accelerator in January 2024. The project has also received financial backing from the Tuscany Region and support from the Fondazione Monte dei Paschi di Siena, underscoring its regional support and alignment with local innovation initiatives. Oraltec's market strategy involves targeting a niche segment within the broader dental industry, leveraging the growing interest in the role of nutrition in systemic and oral health.

Keywords: nutraceuticals for dentistry, oral health supplements, dental nutrition, osteo-immune response, pharmaceutical startups, Florence healthcare, dental professional supplements, scientific nutraceuticals, oral care formulations, post-procedure dental care, pre-treatment dental support, micronutrients for oral health, Italian pharmaceutical, dental innovation, oral pathology supplements, clinical nutrition dentistry